| Literature DB >> 27552033 |
Mehmet Hüseyin Akgul1, Ferruh Gezen2, Ali Kemal Uzunlar3.
Abstract
OBJECTIVE: Esthesioneuroblastoma accounted for only 6% of the malignant nasal cavity neoplasms (ENB) is a rare tumor which originates from the olfactory epithelium. ENB's are locally agresive and can metastasize by lymphatic and hematogenous routes. A patient with the mass on the nasal dorsum was reported in this article. CASE HISTORY: A 52-year-old-man admitted to the hospital with a 3 months history of progressive nasal obstruction, epistaxis and mass on the nasal dorsum. On rhinoscopy, a polypoid mass was seen in the both nasal cavity and intranasal biopsy with local anesthesia was performed. Histopathologic diagnosis of the tumor was Kadish stage B esthesioneuroblastoma. Tumor was excised by using bilateral endoscopic endonasal resection and lateral rhinotomy approach and paranasal radiotherapy performed postoperatively. Ten months after surgery, neck metastasis was occured and patient was underwent neck dissection. Twenteeth months after initial treatment, distant metastasis was identified on the T 10 vertebra and following the cranial and spinal radiotherapy to the neck he was free of local recurrence at follow up 13 months after surgery.Entities:
Keywords: Esthesioneuroblastoma; Methastasis; Thoracal vertebrae
Year: 2016 PMID: 27552033 PMCID: PMC4995531 DOI: 10.1016/j.ijscr.2016.06.015
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1A. T1 thoracal sagittal MRI shows epidural metastatic ENB in T9-10 level. B. T2 thoracal sagittal MRI shows epidural metastatic ENB in T9-10 level, C. T1 thoracal sagittal contrast-enhanced MRI showing intense homogeneous enhancement of epidural metastatic ENB in T9-10 level, and D. T1 thoracal sagittal contrast-enhanced MRI showing intense homogeneous enhancement of epidural metastatic ENB in the left side the T9-10 level of epidural space.
Fig. 2Histologic sections of T9-10 preoperative lesion confirm the impression of a metastatic ENB. The tumor is cellular and is positive for markers of neuronal (neuron specific enolase). As well as of a sustentacular differentiation. Original magnification: ×200.
Cedars-Sinai classification system for metastatic esthesioneuroblastoma to the spine.
| Stage | Anatomic location of lesion |
|---|---|
| CS0-leptomeningeal disease | Involvement of the CSF and leptomeninges (arachnoid and pia mater) |
| CS1a-one level disease | Involves one level of the spine or spinal cord: cervical, thoracic, lumbar, or sacral |
| CS1b-one level disease and leptomeningeal disease | Involves one level of the spine or spinal cord: cervical, thoracic, lumbar, or sacral; with involvement of the CSF and leptomeninges (arachnoid and pia mater) |
| CS2a-two level disease | Involves two levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral |
| CS2b-two level disease and leptomeningeal disease | Involves two levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral; with involvement of the CSF and leptomeninges (arachnoid and pia mater) |
| CS3a-three level disease | Involves three levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral |
| CS3b-three level disease and leptomeningeal disease | Involves three levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral; with involvement of the CSF and leptomeninges (arachnoid and pia mater) |
| CS4a-four level disease | Involves four levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral |
| CS4b-four level disease and leptomeningeal disease | Involves four levels of the spine or spinal cord: cervical, thoracic, lumbar, or sacral; with involvement of the CSF and leptomeninges (arachnoid and pia mater) |